摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

17-oxoestra-1,3,5(10),15-tetraen-3-yl acetate | 59169-10-7

中文名称
——
中文别名
——
英文名称
17-oxoestra-1,3,5(10),15-tetraen-3-yl acetate
英文别名
3-Acetoxyestra-1,3,5(10),15-tetraen-17-on;3-acetoxy-estra-1,3,5 (10),15-tetraen-17-one;[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] acetate
17-oxoestra-1,3,5(10),15-tetraen-3-yl acetate化学式
CAS
59169-10-7
化学式
C20H22O3
mdl
——
分子量
310.393
InChiKey
ABQWAHZTVOQNNH-XSYGEPLQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    246-248 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
  • 沸点:
    462.8±45.0 °C(Predicted)
  • 密度:
    1.172±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    17-oxoestra-1,3,5(10),15-tetraen-3-yl acetate 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 生成 estra-1,3,5(10),15-tetraene-3,17β-diol
    参考文献:
    名称:
    Syntheses of 15α-Hydroxyestrone and 15α-Hydroxyestradiol
    摘要:
    通过新的合成路线,我们从雌酮中制备出了标题化合物(1、2)。用二硼烷对 14、15 或 15、16-双键进行氢硼化合,然后用碱性过氧化氢对有机硼烷进行氧化,很容易在 15α 位上引入羟基。在制备 1 的过程中,为了保护 3、17β-羟基,方便地使用了二甲基叔丁基硅烷官能团。
    DOI:
    10.1248/cpb.23.3141
  • 作为产物:
    描述:
    参考文献:
    名称:
    [EN] PROCESS FOR THE PRODUCTION OF ESTETROL INTERMEDIATES
    [FR] PROCÉDÉ POUR LA PRODUCTION D'INTERMÉDIAIRES D'ESTÉTROL
    摘要:
    本发明涉及一种制备化合物的方法,其化学式为(I),所述方法包括以下步骤:a)将化合物的化学式为(II)与酰化剂或硅化剂反应,生成化合物的化学式为(III),其中P1和P2分别独立地为选自R2-Si-R3R4或R1CO-的保护基,其中R1是选自C1-6烷基或C3-6环烷基的基团,每个基团可选择性地被一个或多个氟或C1-4烷基取代;R2、R3和R4分别独立地为选自C1-6烷基或苯基的基团,每个基团可选择性地被一个或多个氟或C1-4烷基取代;b)在钯醋酸或其衍生物存在下,将化合物的化学式为(III)反应,生成化合物的化学式为(IV);c)将化合物的化学式为(IV)与还原剂反应,生成化合物的化学式为(I)。
    公开号:
    WO2012164096A1
点击查看最新优质反应信息

文献信息

  • PROCESS FOR THE PRODUCTION OF ESTETROL INTERMEDIATES
    申请人:ESTETRA S.A.
    公开号:US20140107358A1
    公开(公告)日:2014-04-17
    The present invention relates to a process for the preparation of a compound of formula (I) said process comprising the steps of: a) reacting a compound of formula (II), with an acylating or a silylating agent to produce a compound of formula (III), wherein P 1 and P 2 are each independently a protecting group selected from R 2− Si—R 3 R 4 , or R 1 CO—, wherein R 1 is a group selected from C 1-6 alkyl or C 3-6 cycloalkyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C 1-4 alkyl; R 2 , R 3 and R 4 are each independently a group selected from C 1-6 alkyl or phenyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C 1-4 alkyl; b) reacting the compound of formula (III) in the presence of palladium acetate or a derivative thereof to produce compound of formula (IV); and c) reacting the compound of formula (IV) with a reducing agent to produce compound of formula (I).
    本发明涉及一种制备式(I)化合物的方法,该方法包括以下步骤:a)将式(II)化合物与酰化剂或化剂反应,以产生式(III)化合物,其中P1和P2各自独立地选择自R2−Si—R3R4或R1CO—的保护基,其中R1为选择自C1-6烷基或C3-6环烷基的基团,每个基团可以选择地被一个或多个取代基独立地选择自或C1-4烷基取代;R2、R3和R4各自独立地选择自C1-6烷基或苯基的基团,每个基团可以选择地被一个或多个取代基独立地选择自或C1-4烷基取代;b)在醋酸或其衍生物的存在下,将式(III)化合物反应,以产生式(IV)化合物;c)将式(IV)化合物与还原剂反应,以产生式(I)化合物。
  • Process for the production of estetrol intermediates
    申请人:Pascal Jean-Claude
    公开号:US11053274B2
    公开(公告)日:2021-07-06
    The present invention relates to a process for the preparation of a compound of formula (I) said process comprising the steps of: a) reacting a compound of formula (II), with an acylating or a silylating agent to produce a compound of formula (III), wherein P1 and P2 are each independently a protecting group selected from R2—Si—R3R4, or R1CO—, wherein R1 is a group selected from C1-6alkyl or C3-6cycloalkyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; R2, R3 and R4 are each independently a group selected from C1-6alkyl or phenyl, each group being optionally substituted by one or more substituents independently selected from fluoro or C1-4alkyl; b) reacting the compound of formula (III) in the presence of palladium acetate or a derivative thereof to produce compound of formula (IV); and c) reacting the compound of formula (IV) with a reducing agent to produce compound of formula (I).
    本发明涉及一种制备式(I)化合物的工艺,所述工艺包括以下步骤:a) 式(II)化合物与酰化剂或硅烷化剂反应生成式(III)化合物,其中 P1 和 P2 各自独立地为选自 R2-Si-R3R4 或 R1CO- 的保护基团,其中 R1 为选自 C1-6 烷基或 C3-6 环烷基的基团,每个基团可任选被一个或多个独立选自或 C1-4 烷基的取代基取代;R2、R3 和 R4 各自独立地为选自 C1-6 烷基或苯基的基团,每个基团任选被一个或多个独立选自或 C1-4 烷基的取代基取代; b) 在乙酸或其衍生物存在下使式 (III) 化合物反应,生成式 (IV) 化合物;以及 c) 使式 (IV) 化合物与还原剂反应,生成式 (I) 化合物。
  • Proton and carbon-13 nuclear magnetic resonance spectroscopy of diastereoisomeric 3- and 17β-tetrahydropyranyl ether derivatives of estrone and estradiol
    作者:Vincent Boucheau、Mélanie Renaud、Marc Rolland de Ravel、Elisabeth Mappus、Claude Y. Cuilleron
    DOI:10.1016/0039-128x(90)90018-7
    日期:1990.5
    Protection of 3- and 17 beta-hydroxyl groups of estrone and estradiol as tetrahydropyranyl ether derivatives led to mixtures of 2'(R)- and 2'(S)-diastereoisomers which were separated by crystallization (3-tetrahydropyranyl ethers), or by thin-layer chromatography (17-tetrahydropyranyl ethers), and characterized by 1H and 13C nuclear magnetic resonance (NMR). Assignments for NMR signals of estradiol 3,17 beta-ditetrahydropyranyl ether were facilitated by comparison with those of its 15 zeta, 16 zeta-dideuterio analog and by 2D 1H-13C heteroshift correlation experiments. Diastereoisomers of 3-tetrahydropyranyl ether derivatives could be identified through the 13C NMR doublet signals of the anomeric C-2' and the aromatic C-4 carbon atoms in CDCl3. Diastereoisomers of 17-tetrahydropyranyl ether derivatives were recognized from characteristic modifications of 1H NMR signals of H-2', H-6', H-1, H-17, and 18-CH3 protons as well as from the 13C NMR doublet signals corresponding to C-2', C-4', C-6', C-12, C-13, C-16, and C-17 carbon atoms. Low-temperature experiments showed a splitting of the C-2', C-6', and C-17 13C NMR signals of each of the two 17-tetrahydropyranyl ether isomers. The downfield signal (equatorial conformer) of the three resulting doublets was more intense for the 17-tetrahydropyranyl ether 2'(S)-isomer, whereas the upfield signal (axial conformer) was more intense for the 2'(R)-isomer.
  • Syntheses of estetrol mqnoglucuronides
    作者:Toshio Nambara、Kenichl Sudo、Motoko Sudo(née Kurata)
    DOI:10.1016/0039-128x(76)90072-6
    日期:1976.1
    Four possible monoglucuronides of estetrol (estra-1,3,5(10)-triene-3,15 alpha, 16 alpha, 17 beta-tetraol) have been prepared from appropriately protected estetrol by the Koenigs-Knorr reaction employing cadmium carbonate as a catalyst. Condensation of methyl acetobromoglucuronate with estetrol 15,16,17-triacetate provided the 3-glucuronide acetate-methyl ester in a satisfactory yield. Introduction of the glucuronyl residue into C-17 was similarly attained by the use of estetrol 3-benzoate 15,16-acetonide. When estetrol 3,17-diacetate and acetobromosugar were stirred in anhydrous toluene in the presence of cadmium salt, the reaction occurred at C-16 and C-15 yielding two isomeric monoglucuronide derivatives in a ratio of ca. 5 to 2. Removal of the protecting groups in the four glucuronide acetate-methyl esters gave the desired estetrol glucuronides, respectively. These synthetic substrates underwent readily enzymatic hydrolysis with beef-liver beta-glucuronidase to afford estetrol.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B